title: Inhibition of caspase-9 by stabilized peptides targeting the dimerization interface.
abstract: Caspases comprise a family of dimeric cysteine proteases that control apoptotic programmed cell death and are therefore critical in both organismal development and disease. Specific inhibition of individual caspases has been repeatedly attempted, but has not yet been attained. Caspase-9 is an upstream or initiator caspase that is regulated differently from all other caspases, as interaction with natural inhibitor X-linked inhibitor of apoptosis protein (XIAP)-baculovirus inhibitory repeat 3 (BIR3) occurs at the dimer interface maintaining caspase-9 in an inactive monomeric state. One route to caspase-9-specific inhibition is to mimic this interaction, which has been localized to the α5 helix of XIAP-BIR3. We have developed three types of stabilized peptides derived from the α5 helix, using incorporation of aminoisobutyric acid, the avian pancreatic polypeptide (aPP)-scaffold or aliphatic staples. The stabilized peptides are helical in solution and achieve up to 32 μM inhibition, indicating that this allosteric site at the caspase-9 dimerization interface is regulatable with low-molecular weight synthetic ligands and is thus a druggable site. The most potent peptides against caspase-9 activity are the aPP-scaffolded peptides. Other caspases, which are not regulated by dimerization, should not be inactivated by these peptides. Given that all of the peptides attain helical structures but cannot recapitulate the high-affinity inhibition of the intact BIR3 domain, it has become clear that interactions of caspase-9 with the BIR3 exosite are essential for high-affinity binding. These results explain why the full XIAP-BIR3 domain is required for maximal inhibition and suggest a path forward for achieving allosteric inhibition at the dimerization interface using peptides or small molecules.
authors.affiliation: Department of Chemistry, University of Massachusetts Amherst, Amherst, MA 01003, USA.
authors.forename: Kristen L
authors.initials: KL
authors.lastname: Huber
authors.forename: Sumana
authors.initials: S
authors.lastname: Ghosh
authors.forename: Jeanne A
authors.initials: JA
authors.lastname: Hardy
mesh_terms: D000494:Allosteric Regulation; D000495:Allosteric Site; D000595:Amino Acid Sequence; D000621:Aminoisobutyric Acids / Q000737:chemistry; D000818:Animals; D017209:Apoptosis; D053453:Caspase 9 / Q000737:chemistry* / Q000235:genetics; D061945:Caspase Inhibitors / Q000737:chemistry*; D019295:Computational Biology; D057075:Enzyme Assays; D006801:Humans; D008024:Ligands; D058977:Molecular Sequence Annotation; D008969:Molecular Sequence Data; D010191:Pancreatic Polypeptide / Q000737:chemistry; D010957:Plasmids / Q000737:chemistry / Q000235:genetics; D011485:Protein Binding; D025941:Protein Interaction Mapping; D055503:Protein Multimerization; D055550:Protein Stability; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D021381:Protein Transport; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000737:chemistry*
chemical_list: D000621:Aminoisobutyric Acids; D061945:Caspase Inhibitors; D008024:Ligands; D051636:X-Linked Inhibitor of Apoptosis Protein; C100049:2-aminoisobutyric acid; C009725:pancreatic polypeptide, avian; D010191:Pancreatic Polypeptide; C506433:CASP9 protein, human; D053453:Caspase 9